Bayer CropScience Limited

Bayer CropScience Limited

BAYERCROP.BO
Bayer CropScience LimitedIN flagBombay Stock Exchange
4,131.75
INR
+12.00
- -
185.53BMarket Cap
Bayer CropScience Limited
BAYERCROP.BO
(Bombay Stock Exchange)

Recent

price

4,131.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
516.14
558.09
664.83
816.59
987.27
744.25
768.74
749.64
715.08
783.01
921.81
1,018.35
1,100.28
1,088.53
1,217.83
- -
1,262.7
Revenue per Share
33.32
35.19
294.11
75.14
104.59
87.34
82.31
86.16
78.46
105.58
109.72
143.58
168.71
164.77
126.38
- -
153.35
Basic EPS, GAAP
12.23
27.01
35.01
73.06
54.73
57.24
44.49
34.85
86.72
138.98
143.45
35.62
118.37
201.57
48.64
- -
- -
Free Cash Flow per Basic Share
4
3.97
4.2
5.11
9.48
17.21
16.94
17.2
29.35
22.58
114.81
149.7
124.85
135
124.78
- -
- -
Dividend per Share
137.4
164.18
423.03
376.35
496.55
417.89
479.38
398.01
447.8
497.24
482.15
465.35
492.79
523.34
523.54
- -
9.99
Book Value per Share
169.47
199.75
488.22
451.75
576.04
506.34
573.49
499.32
511.29
560.39
551.84
541.81
577.94
606.11
603.87
- -
625.32
Tangible Book Value per Share
39
39
39
39
37
36
35
35
43
45
45
45
45
45
45
- -
45
Basic Weighted Avg Shares
20,387
22,044
26,260
31,462
36,153
26,850
27,178
26,111
30,724
35,190
41,428
45,767
49,449
48,921
54,734
56,750
56,750
Sales/Revenue/Turnover
9.96
10.65
12.99
12.17
14.03
16.01
14.82
14.9
15.08
18.99
18
16.61
17.39
18.57
11.05
13.74
13.74
Operating Margin (%)
327
450
462
646
253
247
289
331
438
653
735
645
795
740
849
940
940
Depreciation Expense
1,316
1,390
11,617
2,895
3,830
3,151
2,910
3,001
3,371
4,745
4,931
6,453
7,582
7,405
5,680
6,892
6,892
Net Income, GAAP
33.8
32
25.68
34.32
33.22
34.57
35.03
25.68
29.77
18.62
37.94
23.8
23.42
21.34
19.71
19.38
19.38
Effective Tax Rate (%)
6.46
6.31
44.24
9.2
10.59
11.74
10.71
11.49
10.97
13.48
11.9
14.1
15.33
15.14
10.38
12.14
12.14
Profit Margin (%)
5,204
4,861
15,562
12,583
17,753
14,995
16,911
14,142
15,919
18,750
19,733
19,162
21,189
23,081
22,479
23,508
23,508
Working Capital
1,085
- -
- -
- -
- -
- -
- -
- -
- -
138
141
518
364
210
616
388
388
LT Debt
6,730
7,927
19,313
17,423
21,106
18,394
20,567
17,783
22,394
25,725
25,503
25,243
27,121
28,494
28,504
29,657
29,657
Total Equity
17.19
18.98
18.62
13.69
17.54
14.21
13.41
15.05
16.18
22.36
17.45
21.79
24.27
25.15
16.62
20.95
20.95
Return on Invested Capital (%)
19.13
19.91
100.41
18.75
23.63
19.34
18.45
20.03
20.81
23.11
22.4
29.98
34.72
32.25
23.95
54.56
54.56
Return on Capital (%)
23.87
23.34
100.17
18.55
23.44
18.95
18.17
19.48
20.37
22.82
22.41
30.31
35.22
32.43
24.14
57.48
57.48
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
453
- -
430
LT Borrowings
- -
- -
- -
LT Finance Leases
567
- -
388
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
45
- -
45
Market Capitalization
216,056
204,984
209,059

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
43,997
- -
49,183
Cash, Cash Equivalents & STI
7,164
- -
14,914
Accounts Receivable, Net
17,663
- -
11,155
Inventories
16,607
- -
21,355
Total Current Liabilities
19,172
- -
25,675
Payables & Accruals
- -
- -
- -
ST Debt
453
- -
430
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.38%
3.11%
4.05%
Free Cash Flow
74.65%
103.08%
363.86%
Net Income, GAAP
9.66%
8.82%
21.34%
Sales/Revenue/Turnover
8.02%
6.6%
3.68%
Total Cash Common Dividend
- -
2.94%
0.36%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17,396
16,172
9,549
5,804
48,921
2025
16,312
17,382
10,569
10,464
54,734
2026
19,146
15,534
11,062
11,008
56,750

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
73.09
49.6
20.72
- -
164.77
2025
56.56
30.33
7.61
31.88
126.38
2026
62.01
33.98
21.29
36.07
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
135
2025
- -
- -
- -
- -
124.78
2026
- -
- -
- -
- -
- -
Business
Bayer CropScience Limited operates as an Indian agrochemical company primarily engaged in the manufacture and sale of crop protection products, seeds, and digital farming solutions. Its core product portfolio includes herbicides, insecticides, fungicides, biopesticides, bio-stimulants, seed treatments, and genetically improved seeds for crops such as corn, soybean, rice, cotton, fruits, and vegetables. The company leverages its digital farming platform Climate FieldView to offer precision agriculture tools, data analytics, and real-time farm management solutions. Founded in 2000 and headquartered in Mumbai, Bayer CropScience operates primarily in India but is linked to its global parent Bayer AG, enabling it to access cutting-edge agricultural technologies and innovations. In the last two years, Bayer CropScience has made several strategic operational enhancements, including the acquisition of a canola treating and packaging facility in Coaldale, Alberta, Canada, from HyTech Production Ltd, which closed in November 2024. This acquisition aims to integrate operations of canola seed production and packaging to enhance supply chain visibility and quality control. Additionally, Bayer continues to expand its biological solutions offerings emphasizing sustainable farming practices through biopesticides and bio-stimulants. In product innovation, Bayer CropScience has advanced its digital farming tools, helping farmers optimize resources and increase yields using data-driven decision-making processes. These moves reflect Bayer CropScience's commitment to growth, quality, sustainability, and increasing value for farmers in its target markets. Bayer CropScience Limited serves the agricultural industry with a focus on crop protection, seeds and traits, and digital farming segments. It targets commercial farmers, seed growers, and agribusinesses, supplying products essential for crop health and productivity. The company maintains strong R&D capabilities and global synergies from Bayer AG's CropScience division, while retaining local market responsiveness. Bayer CropScience's broad product range and recent operational expansions underscore its leadership role in the Indian and broader global agritech and agrochemical markets.